Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Pharma Companies get Innovative, use Indegene’s App for Apple Watch for Ethical Marketing and Reaching out to Doctors
(NewsVoir); Necessity is the mother of all invention. Pharmaceuticals industry just got innovative in reaching out to doctors with the latest app for Apple Watch under the Ethical Marketing norms. Developed by Indegene, the leading provider of healthcare solutions to the global pharmaceuticals industry, medical insurers and hospitals in the US, has developed the latest app for the Apple Watch for the healthcare industry to engage with doctors. This app augurs well for the Pharma industry already reeling under pressures of compliance norms for ethical marketing to doctors.
- Read more about Perrigo receive US FDA approval for generic BenzaClin topical gel
Perrigo Company plc, received US Food and Drug Administration (FDA) approval for the generic version of Valeant Pharmaceutical International Inc's BenzaClin topical gel.

[adsense:336x280:8701650588]
- Read more about MicrocynAH next-gen dermatology products with dimethicone for animals Launch by Oculus Innovative Sciences
Oculus Innovative Sciences, Inc., a specialty pharmaceutical company, introduce two new MicrocynAH dermatology products for animals.
- Read more about Childhood Brain Tumors Impact Working Memory during Adulthood
A new study has suggested that survivors of childhood brain tumors have lower working memory performance in adulthood compared to healthy adults. The study appeared in the Journal of the International Neuropsychological Society.
- Read more about B. Braun's Infusomat Space Pump get US FDA approval
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, has received 510(k) clearance for its second-generation, large-volume Infusomat Space Pump.
- Read more about Drug combination improves progression-free survival in melanoma patients regardless of genetic status, age and spread of disease
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
- Read more about European Union approved Praluent® (alirocumab) for the treatment of hypercholesterolemia
European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the treatment of bad cholesterol, known as low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. Praluent is the only EC-approved PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor that is available in two starting doses as a single 1-milliter (mL) injection (75 mg and 150 mg) once every two weeks, offering two levels of efficacy. Praluent will be available in a single-dose pre-filled pen that patients self-administer.
- Read more about DNA-based nanodevices for molecular medicine
Self-assembled DNA nanostructures can be used in molecular-scale diagnostics and as smart drug-delivery vehicles.
Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications. In the review article, the researchers outline the superior properties of DNA nanostructures, and how these features enable the development of efficient biological DNA-nanomachines. Moreover, these DNA nanostructures provide new applications in molecular medicine, such as novel approaches in tackling cancer. Tailored DNA structures could find targeted cells and release their molecular payload (drugs or antibodies) selectively into these cells.
- Read more about Pfizer in US market launch Centrum VitaMints multivitamin tablets
Pfizer Consumer Healthcare launch Centrum VitaMints, a great-tasting and easy-to-take multivitamin in US Market. Centrum VitaMints is a refreshing and complete multivitamin that provides a more enjoyable experience for consumers to get essential nutrients, and joins other Centrum products to form one of the most comprehensive lines of multivitamins on the market.
- Read more about Paralyzed Man to Walk Again by Brain Control System
Researchers have used non-invasive direct brain control system to get a person, with complete paralysis in both legs owing to spinal cord injury, to walk again. The research was published in the Journal of NeuroEngineering and Rehabilitation.